Search PDMR transactions

Notifier
Name of person with notification obligation
Bent Frandsen
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Bent Frandsen
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Expres2ion Biotech Holding AB
Issuer´s LEI code
549300FJK50P1ORYJC45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Warrant ExpreS2ion Biotech Hold. TO10 SE0022088100 Acquisition 117,108 Quantity 0.043 SEK 14/11/2024 FIRST NORTH SWEDEN
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
ExpreS2ion Biotech Hold. TO10 SE0022088100 Acquisition 14/11/2024 FIRST NORTH SWEDEN 117,108 (Quantity) 0.043 SEK
Total: 117,108
<< Back